Literature DB >> 10833421

p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53.

A Ikeda1, X Sun, Y Li, Y Zhang, R Eckner, T S Doi, T Takahashi, Y Obata, K Yoshioka, K Yamamoto.   

Abstract

p53 and NF-kappaB RelA are activated by various genotoxic agents and mutually suppress each other's ability to activate transcription, most likely through competition for transcriptional coactivators such as CBP or p300. However, we found that the inhibition by RelA of p53 transcriptional activity is not completely restored by CBP/p300 overexpression and that a p53 mutant can not suppress RelA activity despite of its ability to bind CBP/p300. In the present study, we further present evidence that these two transcriptional factors directly interact both in vivo and in vitro. These results therefore indicate that the cross transcriptional interference between p53 and RelA is partly caused by the direct interaction between these two transcription factors which is mediated by their dimerization/tetramerization domains and results in inhibition of each other's transcriptional activity. Finally, cells derived from RelA knockout mice showed enhanced p53 transcriptional activity, suggesting that this cross transcriptional interference is physiologically important in cellular response to genotoxic stress. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833421     DOI: 10.1006/bbrc.2000.2786

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

1.  Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.

Authors:  M Nees; J M Geoghegan; T Hyman; S Frank; L Miller; C D Woodworth
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  ZBP-89 promotes growth arrest through stabilization of p53.

Authors:  L Bai; J L Merchant
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

Review 3.  New insights into the role of nuclear factor-kappaB in cell growth regulation.

Authors:  F Chen; V Castranova; X Shi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 4.  p53-mediated neuronal cell death in ischemic brain injury.

Authors:  Li-Zhi Hong; Xiao-Yuan Zhao; Hui-Ling Zhang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

5.  RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.

Authors:  Emilie Jacque; Thierry Tchenio; Guillaume Piton; Paul-Henri Romeo; Véronique Baud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-28       Impact factor: 11.205

6.  Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB.

Authors:  Wei-Chien Huang; Tsai-Kai Ju; Mien-Chie Hung; Ching-Chow Chen
Journal:  Mol Cell       Date:  2007-04-13       Impact factor: 17.970

7.  Transcriptional regulation of microRNA-100, -146a, and -150 genes by p53 and NFκB p65/RelA in mouse striatal STHdh(Q7)/ Hdh(Q7) cells and human cervical carcinoma HeLa cells.

Authors:  Jayeeta Ghose; N P Bhattacharyya
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

8.  A novel mechanism of crosstalk between the p53 and NFκB pathways: MDM2 binds and inhibits p65RelA.

Authors:  Kristina Heyne; Christine Winter; Fabian Gerten; Christina Schmidt; Klaus Roemer
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

Review 9.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

10.  Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.

Authors:  Sathish Sadagopan; Neelam Sharma-Walia; Mohanan Valiya Veettil; Hari Raghu; Ramu Sivakumar; Virginie Bottero; Bala Chandran
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.